Clinical Trials Browser

Phase 2 × Bleomycin × 90 days × Clear all

NCT03755804 2026-04-23

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Phase 2 Active not recruiting

Hodgkin Disease, Neoplasms